Biologics will participate in late-stage trial of Neupogen

02/11/2010 | American City Business Journals

The National Marrow Donor Program chose North Carolina's Biologics to oversee inventory and distribution of Neupogen, a drug that boosts white blood cells, during a Phase III trial involving blood stem cell transplant patients with unrelated donors. The trial has been going on since 1997 and is expected to enroll 15,000 participants by 2012.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health